FDA panel recommends move toward streamlined COVID vaccine approach

The Food and Drug Administration (FDA) vaccine advisory group today recommended streamlining COVID-19 vaccine campaigns by offering just the newer bivalent (two-strain) versions of the vaccine for both primary and booster series. The measure, which passed unanimously, capped off a full day of reviewing the latest safety and efficacy data from all of the companies that produce vaccine for the US…

Read the full article here

Related Articles